The meeting will start promptly at 10:30 and is anticipated to finish by 16:30
Please note that this agenda is subject to change prior to the meeting.
1. Welcome and introduction to format of meeting - Part 1 only (open session)
2. Apologies - Part 1 only (open session)
3. Any other business - Part 1 only (open session)
4. Assessment of The Triage PlGF test, Elecsys immunoassay sFlt-1/PlGF ratio, DELFIA Xpress PlGF 1-2-3 test and BRAHMS sFlt-1 Kryptor / PlGF plus Kryptor PE ratio to aid the assessment of suspected pre-eclampsia
4.1. Declarations of interest - Part 1 only (open session)
4.2. Introduction by the Chair, Professor Adrian Newland - Part 1 only (open session)
4.3. Presentation by the Lead team, Professor Jimmy Walker, Professor of Obstetrics and Gynaecology, and Mark Kroese, Consultant in Public Health - Part 1 AND Part 2 (open and closed session)
4.4. Agreement on the content of the Diagnostics Consultation Document (DCD) - Part 2 only (closed session)
5.1. Declarations of interest - Part 1 only (open session)
5.2. Introduction by the Chair, Professor Adrian Newland - Part 1 only (open session)
5.3. Consideration of public consultation comments - Part 1 AND Part 2 (open and closed session)
5.4. Agreement on the content of the Diagnostics Guidance Document (DGD) - Part 2 only (closed session)
Date, time and venue of next Diagnositcs Advisory Committee meeting
Wednesday 04 November 2015 10.30 –16.30, NICE, Level 1a, City Tower, Piccadilly Plaza, Manchester, M1 4BT
Please note all timings are approximate.
To print this agenda, please right click and select ‘Print’ from the menu
You will receive an automated email response when you submit the registration form. If you do not receive this automated response your registration request has not been received, and you will need to complete and submit the registration form again.
The closing date for registration is Wednesday 16 September 2015. Please note that it may not be possible to accept late registration requests.
Should you have queries regarding attending this meeting, please contact the Meetings in Public Coordinator, Sandra Robinson, at email@example.com
Please note that registrants wishing to conduct a research study on the committee meeting and/or NICE processes will require prior permission and should contact NICE Enquiry Handling by email firstname.lastname@example.org.
Further information about conducting research is also available in our Common Questions and Answers about meetings in public document.